Global GERD Market Professional Survey Report 2019
Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.
The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.
The Americas will be the highest revenue generating market segment during the forecast period. The high incidence of GERD in this region will lead to the increase in consumption of various drugs meant to treat the patients.
The global GERD market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on GERD volume and value at global level, regional level and company level. From a global perspective, this report represents overall GERD market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of GERD in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their GERD manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM
Segment by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.
The Americas will be the highest revenue generating market segment during the forecast period. The high incidence of GERD in this region will lead to the increase in consumption of various drugs meant to treat the patients.
The global GERD market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on GERD volume and value at global level, regional level and company level. From a global perspective, this report represents overall GERD market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of GERD in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their GERD manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM
Segment by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
